We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.18T
$1.26B 6.29%
6,762,037
-133,882
-2% -$24.9M
MSFT icon
2
Microsoft
MSFT
$2.88T
$1.25B 6.25%
2,589,450
-14,458
-0.6% -$7.25M
AAPL icon
3
Apple
AAPL
$4.75T
$912M 4.55%
3,353,628
-48,399
-1% -$13M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.25T
$790M 3.94%
2,522,280
+161,460
+7% +$46.1M
AMZN icon
5
Amazon
AMZN
$2.61T
$578M 2.88%
2,505,208
+167,519
+7% +$38.3M
AVGO icon
6
Broadcom
AVGO
$1.89T
$496M 2.47%
1,433,369
-7,185
-0.5% -$2.57M
LLY icon
7
Eli Lilly
LLY
$1.04T
$480M 2.39%
446,264
-13,828
-3% -$13.2M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.24T
$253M 1.26%
804,654
-91,259
-10% -$26.1M
ABBV icon
9
AbbVie
ABBV
$451B
$246M 1.23%
1,077,633
+241,917
+29% +$55.1M
MA icon
10
Mastercard
MA
$471B
$238M 1.19%
417,074
-14,805
-3% -$8.28M
TSM icon
11
TSMC
TSM
$2.19T
$232M 1.16%
763,801
-107,061
-12% -$31.4M
GILD icon
12
Gilead Sciences
GILD
$164B
$225M 1.12%
1,832,185
+211,788
+13% +$25.7M
V icon
13
Visa
V
$675B
$216M 1.08%
616,575
+78,791
+15% +$26.8M
JPM icon
14
JPMorgan Chase
JPM
$922B
$201M 1%
622,691
-50,058
-7% -$15.5M
PANW icon
15
Palo Alto Networks
PANW
$275B
$198M 0.99%
1,073,219
+38,007
+4% +$7.67M
LRCX icon
16
Lam Research
LRCX
$401B
$178M 0.89%
1,042,511
-69,644
-6% -$10.8M
TMO icon
17
Thermo Fisher Scientific
TMO
$196B
$173M 0.86%
297,719
+25,605
+9% +$14.5M
MCK icon
18
McKesson
MCK
$96.4B
$168M 0.84%
205,294
+15,108
+8% +$12.3M
META icon
19
Meta Platforms (Facebook)
META
$1.59T
$165M 0.82%
249,919
-66,213
-21% -$44.2M
ISRG icon
20
Intuitive Surgical
ISRG
$121B
$165M 0.82%
291,042
+20,962
+8% +$11.2M
CRM icon
21
Salesforce
CRM
$133B
$163M 0.81%
615,586
-38,580
-6% -$9.59M
REGN icon
22
Regeneron Pharmaceuticals
REGN
$68.4B
$158M 0.79%
205,332
+35,837
+21% +$24.3M
JNJ icon
23
Johnson & Johnson
JNJ
$613B
$155M 0.77%
749,599
+113,575
+18% +$22.5M
MU icon
24
Micron Technology
MU
$1.11T
$151M 0.75%
528,840
-51,980
-9% -$11.9M
MRK icon
25
Merck
MRK
$316B
$134M 0.67%
1,275,687
-143,474
-10% -$13.5M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.